Multiple myeloma and Fluid retention

Summary:

Fluid retention is found among people with Multiple myeloma, especially for people who are male, 60+ old.

The study analyzes which people have Fluid retention with Multiple myeloma. It is created by eHealthMe based on reports of 1,527 people who have Multiple myeloma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple myeloma?

Multiple myeloma (cancer of the plasma cells) is found to be associated with 1,107 drugs and 1,404 conditions by eHealthMe. Check the latest studies of Multiple myeloma.

What is Fluid retention?

Fluid retention (an abnormal accumulation of fluid in the blood) is found to be associated with 1,702 drugs and 2,444 conditions by eHealthMe. Check the latest studies of Fluid retention.

On Jul, 26, 2026

1,527 people who have Multiple Myeloma and Fluid Retention are studied.

Would you have Fluid retention when you have Multiple myeloma?

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Fluid retention?

- Check whether Fluid retention is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Multiple myeloma (516,725 reports)
Fluid retention (79,660 reports)

All the drugs that are associated with Fluid retention:

Fluid retention (1,702 drugs)

All the conditions that are associated with Fluid retention:

Fluid retention (2,444 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Fluid retention and Multiple myeloma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Multiple myeloma and Fluid retention

Summary:

What is Multiple myeloma?

What is Fluid retention?

Gender of people who have Multiple myeloma and experienced Fluid retention *:

Age of people who have Multiple myeloma and experienced Fluid retention *:

Common co-existing conditions for these people *:

Common drugs taken by these people *:

Common symptoms for these people *: